| NAV | $14.75 | Daily Change | -$0.18 | -1.21% |
| Market Price | $14.65 | Daily Change | -$0.14 | -0.95% |
CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.
In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.
The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.
| Inception Date | 12/07/18 |
| Total Expense Ratio | 0.65% |
| Net Assets | $9.15 million |
| NAV | $14.75 |
| Fact Sheet | View the document |
The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).
The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.
| Ticker | CHIH |
| Bloomberg Index Ticker | NU722071 |
| CUSIP | 37954Y541 |
| ISIN | US37954Y5419 |
| Primary Exchange | NYSE Arca |
| Shares Outstanding | 620,002 |
| Number of Holdings | 77 |
| 30-Day Median Bid-Ask Spread | 1.79% |
| 30-Day SEC Yield | 0.57% |
| Distribution Frequency | Semi-Annually |
| NAV | $14.75 | Daily Change | -$0.18 | -1.21% |
| Market Price | $14.65 | Daily Change | -$0.14 | -0.95% |
|
As of recent (09/30/23)
As of recent (09/30/23)
|
Fund NAV | Market Price | Index |
|---|---|---|---|
| 1 Year | 4.28% | 3.93% | 5.04% |
| 3 Years | -15.91% | -16.43% | -15.35% |
| Since Inception | -1.29% | -1.51% | -0.59% |
| 1 Year | 8.60% | 10.00% | 9.40% |
| 3 Years | -14.80% | -14.77% | -14.22% |
| Since Inception | -0.32% | -0.18% | 0.39% |
| Year-to-Date | -16.77% | -16.73% | -16.41% |
| 1 Month | 0.36% | -0.80% | 0.40% |
| 3 Months | -0.93% | -2.14% | -0.79% |
| Since Inception | -6.04% | -7.06% | -2.79% |
| Year-to-Date | -12.81% | -11.20% | -12.35% |
| 1 Month | 4.76% | 6.63% | 4.86% |
| 3 Months | -3.00% | -2.34% | -2.81% |
| Since Inception | -1.57% | -0.89% | 1.93% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 9.16 | 2269 HK | WUXI BIOLOGICS CAYMAN INC | BL6B9P1 | 5.76 | 146,080 | 841,624.74 |
| 7.71 | 6160 HK | BEIGENE LTD | BGDY260 | 14.09 | 50,239 | 707,823.08 |
| 7.01 | 1093 HK | CSPC PHARMACEUTI | 6191997 | 0.89 | 721,608 | 643,528.13 |
| 5.74 | 1801 HK | INNOVENT BIOLOGICS INC | BGR6KX5 | 5.61 | 93,900 | 527,138.87 |
| 4.53 | 1177 HK | SINO BIOPHARMACEUTICAL | B00XSF9 | 0.48 | 860,800 | 416,413.69 |
| 3.93 | 2359 HK | WUXI APPTEC CO LTD-H | BGHH0L6 | 11.92 | 30,256 | 360,668.84 |
| 3.21 | LEGN | LEGEND BIOTECH CORP-ADR | BMX9K07 | 60.49 | 4,872 | 294,707.28 |
| 3.16 | 1548 HK | GENSCRIPT BIOTECH CORP | BD9Q2J2 | 2.90 | 100,071 | 290,200.44 |
| 3.14 | 1099 HK | SINOPHARM GROUP CO-H | B3ZVDV0 | 2.57 | 112,300 | 288,198.12 |
| 2.75 | 9926 HK | AKESO INC | BLFJ7Y1 | 6.01 | 42,000 | 252,487.73 |
| 2.68 | 300760 C2 | SHENZHEN MINDR-A | BHQK864 | 39.58 | 6,217 | 246,087.05 |
| 2.38 | 9688 HK | ZAI LAB LTD | BP8L269 | 2.80 | 77,940 | 218,521.03 |
| 2.36 | 600276 C1 | JIANGSU HENGRU-A | BP3R369 | 6.56 | 33,072 | 216,933.02 |
| 2.33 | 867 HK | CHINA MEDICAL SY | B6WY993 | 1.80 | 119,100 | 214,260.03 |
| 2.22 | 1066 HK | SHANDONG WEIG-H | 6742340 | 0.97 | 209,900 | 203,617.75 |
| 2.19 | 3692 HK | HANSOH PHARMACEU | BJYKB72 | 1.90 | 106,100 | 201,220.03 |
| 2.07 | 6078 HK | HYGEIA HEALTHCAR | BMX09H0 | 6.36 | 29,800 | 189,661.57 |
| 1.80 | 603259 C1 | WUXI APPTEC CO LTD-A | BHWLWV4 | 11.71 | 14,124 | 165,351.84 |
| 1.63 | 1530 HK | 3SBIO INC | BY9D3L9 | 0.96 | 155,800 | 149,537.61 |
| 1.44 | 570 HK | TRAD CHI MED | 6971779 | 0.49 | 271,700 | 131,784.04 |
| 1.36 | 300122 C2 | CHONGQING ZHIF-A | BD5CJY8 | 9.24 | 13,549 | 125,214.53 |
| 1.31 | 300015 C2 | AIER EYE HSPTL-A | BD5CLQ4 | 2.40 | 50,013 | 120,163.74 |
| 1.29 | 600436 C1 | ZHANGZHOU PIEN-A | BP3R7Z6 | 35.75 | 3,316 | 118,534.51 |
| 1.27 | 853 HK | MICROPORT SCIENTIFIC CORP | B676TW7 | 1.64 | 71,000 | 116,613.74 |
| 1.20 | 2196 HK | FOSUN PHARMA-H | B8XBQ96 | 2.37 | 46,600 | 110,382.19 |
| 1.11 | 2607 HK | SHANGHAI PHARM-H | B4Q4CJ6 | 1.50 | 67,600 | 101,487.83 |
| 1.02 | 3320 HK | CHINA RESOURCES | BYNGG26 | 0.66 | 141,100 | 93,604.98 |
| 0.86 | 000538 C2 | YUNNAN BAIYAO-A | BD5CP95 | 7.08 | 11,114 | 78,648.96 |
| 0.73 | 000963 C2 | HUADONG MEDICINE CO LTD-A | BD5CM94 | 5.72 | 11,711 | 66,930.76 |
| 0.65 | 600085 C1 | BEIJING TONGRENTANG CO-A | BP3R5C9 | 7.26 | 8,200 | 59,563.64 |
| 0.62 | 300896 C2 | IMEIK TECHNOLO-A | BNR4MY3 | 45.57 | 1,251 | 57,001.93 |
| 0.60 | 600196 C1 | SHANGHAI FOSUN-A | BP3R3M5 | 3.98 | 13,874 | 55,266.40 |
| 0.57 | 000661 C2 | CHANGCHUN HIGH-A | BD5CDB3 | 22.06 | 2,365 | 52,178.35 |
| 0.54 | 300832 C2 | SHENZHEN NEW-A | BMXTX20 | 9.60 | 5,200 | 49,931.51 |
| 0.52 | 002001 C2 | ZHEJIANG NHU CO LTD-A | BD5CH66 | 2.37 | 20,168 | 47,780.11 |
| 0.51 | 002252 C2 | SHANGHAI RAAS -A | BD5CPJ5 | 1.05 | 44,800 | 46,837.56 |
| 0.51 | 600332 C1 | GUANGZHOU BAIY-A | BP3R4Q6 | 4.30 | 10,859 | 46,640.91 |
| 0.49 | 002422 C2 | SICHUAN KELUN-A | BD5CL08 | 3.96 | 11,400 | 45,140.47 |
| 0.49 | 600161 C1 | BEIJING TIAN-A | BP3R9J4 | 4.28 | 10,500 | 44,893.50 |
| 0.48 | 601607 C1 | SHANG PHARM -A | BP3R4Z5 | 2.55 | 17,300 | 44,104.77 |
| 0.47 | 002821 C2 | ASYMCHEM LABOR-A | BD6V5C4 | 19.81 | 2,158 | 42,740.14 |
| 0.46 | 300759 C2 | PHARMARON BEIJ-A | BK4XYC4 | 4.49 | 9,400 | 42,213.68 |
| 0.46 | 000999 C2 | CHINA RESOURCE-A | BD5CL42 | 6.99 | 6,000 | 41,931.07 |
| 0.46 | 002294 C2 | SHENZHEN SALUBRIS PHARM-A | BD5CM05 | 4.54 | 9,200 | 41,804.15 |
| 0.45 | 002603 C2 | SHIJIAZHUANG Y-A | BD5CHJ9 | 3.63 | 11,427 | 41,478.10 |
| 0.44 | 000423 C2 | DONG-E-E-JIAOCO LTD-A | BD5CM61 | 6.99 | 5,800 | 40,533.36 |
| 0.43 | 002007 C2 | HUALAN BIOLOGI-A | BD5CL19 | 3.27 | 12,070 | 39,476.42 |
| 0.41 | 600998 C1 | JOINTOWN PHARMACEUTICAL-A | BP3R541 | 1.05 | 36,124 | 37,918.44 |
| 0.40 | 600079 C1 | HUMANWELL HEAL-A | BP3R712 | 3.33 | 11,100 | 36,940.01 |
| 0.38 | 603392 C1 | BEIJING WANTAI-A | BMXTWX4 | 6.79 | 5,086 | 34,512.80 |
| 0.37 | 300142 C2 | WALVAX BIOTECHNOLOGY CO-A | BD5CG36 | 3.35 | 10,100 | 33,880.30 |
| 0.37 | 002044 C2 | MEINIAN ONEHEA-A | BD73L10 | 0.87 | 38,820 | 33,803.23 |
| 0.36 | 688180 C1 | SHANGHAI JUNSH-A | BLCD7F7 | 6.17 | 5,293 | 32,654.94 |
| 0.35 | 300601 C2 | SHENZHEN KANGT-A | BFY8HT2 | 4.14 | 7,648 | 31,673.36 |
| 0.34 | 688363 C1 | BLOOMAGE BIOTE-A | BP91NT8 | 10.57 | 2,952 | 31,213.32 |
| 0.34 | 002223 C2 | JIANGSU YUYUE-A | BD5CJM6 | 4.71 | 6,600 | 31,115.37 |
| 0.33 | 600566 C1 | HUBEI JUMPCAN -A | BS7K3N2 | 4.44 | 6,800 | 30,214.41 |
| 0.32 | 603882 C1 | GUANGZHOU KING-A | BFYX689 | 9.34 | 3,140 | 29,312.69 |
| 0.32 | 603858 C1 | SHANDONG BUCHA-A | BYW5NC3 | 2.52 | 11,587 | 29,248.49 |
| 0.31 | 300347 C2 | HANGZHOU TIGER-A | BD5CCK5 | 8.87 | 3,216 | 28,525.33 |
| 0.31 | 300003 C2 | LEPU MEDICAL TECHNOLOGY-A | BD5CM16 | 2.39 | 11,901 | 28,494.13 |
| 0.31 | 603658 C1 | AUTOBIO DIAGNO-A | BYW5N89 | 6.73 | 4,200 | 28,248.12 |
| 0.29 | 300558 C2 | BETTA PHARMACE-A | BD6QWL7 | 7.87 | 3,420 | 26,912.20 |
| 0.29 | 002262 C2 | JIANGSU NHWA -A | BD5M197 | 3.56 | 7,500 | 26,668.16 |
| 0.29 | 600380 C1 | JOINCARE PHARM-A | BP3RBV0 | 1.77 | 14,800 | 26,229.84 |
| 0.28 | 600129 C1 | CHONGQING TAIJI | BMF7PZ9 | 6.28 | 4,100 | 25,764.68 |
| 0.28 | 600763 C1 | TOPCHOICE MEDI-A | BYYFJH8 | 11.92 | 2,155 | 25,692.77 |
| 0.28 | 688301 C1 | IRAY TECHNOLOGY CO LTD-A | BQ3RXC2 | 31.39 | 806 | 25,298.89 |
| 0.28 | 603456 C1 | ZHEJIANG JIUZH-A | BMQBVL8 | 3.77 | 6,700 | 25,265.70 |
| 0.27 | 603707 C1 | NANJING KING-F-A | BF2DZL7 | 1.98 | 12,636 | 25,079.14 |
| 0.26 | 000513 C2 | LIVZON PHARM-A | BD5CQ25 | 4.85 | 4,900 | 23,765.13 |
| 0.25 | 600521 C1 | ZHEJIANG HUAHA-A | BP3RBR6 | 2.23 | 10,410 | 23,178.28 |
| 0.25 | 600511 C1 | CHINA NATIONAL-A | BP3R9B6 | 4.13 | 5,600 | 23,144.83 |
| 0.25 | 300676 C2 | BGI GENOMICS CO LTD-A | BFY8H58 | 7.29 | 3,133 | 22,836.49 |
| 0.25 | 000739 C2 | APELOA PHARMA-A | BD5LY17 | 2.37 | 9,500 | 22,479.94 |
| 0.25 | 300595 C2 | OVCTEK CHINA INC-A | BHQPSJ2 | 3.50 | 6,424 | 22,474.03 |
| 0.23 | 600056 C1 | CHINA MEHECO CO LTD -A | BP3R8X1 | 1.73 | 12,100 | 20,886.56 |
| 0.06 | CASH | 1.00 | 5,291 | 5,291.01 | ||
| 0.03 | OTHER PAYABLE & RECEIVABLES | 1.00 | 2,782 | 2,781.60 | ||
| 0.02 | HONG KONG DOLLAR | 0.13 | 15,113 | 1,939.22 | ||
| 0.00 | CHINESE YUAN RENMINBI | 0.14 | 810 | 113.21 |
| Industry | Weight (%) | |
|---|---|---|
| Pharmaceuticals: Major | 37.0 | |
| Biotechnology | 32.7 | |
| Pharmaceuticals: Other | 10.0 | |
| Medical Specialties | 7.9 | |
| Pharmaceuticals: Generic | 7.4 | |
| Hospital/Nursing Management | 1.7 | |
| Miscellaneous Commercial Services | 1.0 | |
| Chemicals: Specialty | 1.0 | |
| Medical Distributors | 0.4 | |
| Apparel/Footwear | 0.4 | |
| Services to the Health Industry | 0.3 | |
| Other | 0.2 |
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.